Absci Corporation

NasdaqGS ABSI

Absci Corporation Free Cash Flow Yield on February 06, 2025: -13.05%

Absci Corporation Free Cash Flow Yield is -13.05% on February 06, 2025, a 13.10% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.

Absci Corporation 52-week high Free Cash Flow Yield is -9.51% on April 09, 2024, which is 27.15% above the current Free Cash Flow Yield.
Absci Corporation 52-week low Free Cash Flow Yield is -24.16% on November 21, 2024, which is -85.10% below the current Free Cash Flow Yield.
Absci Corporation average Free Cash Flow Yield for the last 52 weeks is -15.37%.

Key data

Date	Free Cash Flow Yield	Market Value Added (MVA)	Price to Book Ratio (P/B)	Price to Earnings Ratio (P/E)

NasdaqGS: ABSI

Absci Corporation

CEO	Mr. Sean McClain
IPO Date	July 22, 2021
Location	United States
Headquarters	18105 SE Mill Plain Boulevard
Employees	155
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Drugstores & Retail Pharmacies Fintech

Description

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.

Key trends

Past 5 years